A grounded discussion on longevity, separating real science from marketing hype as the field goes mainstream.
We explore what changed in recent years, key longevity metrics, the influencer effect, and where attention truly belongs—from lifestyle fundamentals to supplements and GLP-1 drugs.

A candid debate on whether value-based care is a real alternative to fee-for-service or an expensive illusion.
We examine what “value” really means, which metrics matter, and whether VBC success stories can truly scale beyond isolated cases.

An in-depth look at the crowded medical AI scribe market and why so many tools exist for the same problem.
We examine where the real innovation lies, the risks involved, and whether AI scribes truly move healthcare toward value-based care—or just attract VC hype.

A sharp debate on whether VC culture has harmed digital health, unpacking how aggressive investment tactics shape innovation, sustainability, and exits.

We explore the future of digital health funding and whether AI can help founders rely less on venture capital.

A clear-eyed discussion on Generative AI in healthcare, separating real clinical impact from hype.

We break down where AI truly improves patient care and diagnostics—and where the promises fall short.